Back to today’s briefing

Story perspectives

2025 Sees Record $240B Biotech Acquisitions and CEO Honors

12/17/2025

41 4

Summary

Story summary

In 2025, biotech and pharmaceutical sectors saw nearly $240 billion in acquisition deals, the highest total since 2019.
Adam Feuerstein, senior writer and biotech columnist, announced the winners of his 2025 Best Biopharma CEO honor, praising the exceptional performance of several CEOs.
He also co-hosts the biotech podcast The Readout Loud and writes the newsletter Adam’s Biotech Scorecard.

1 of 1

Story summary

In 2025, biotech and pharmaceutical sectors saw nearly $240 billion in acquisition deals, the highest total since 2019.
Adam Feuerstein, senior writer and biotech columnist, announced the winners of his 2025 Best Biopharma CEO honor, praising the exceptional performance of several CEOs.
He also co-hosts the biotech podcast The Readout Loud and writes the newsletter Adam’s Biotech Scorecard.